4//SEC Filing
Hall Ashley 4
Accession 0001628280-21-001177
CIK 0001434868other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 5:01 PM ET
Size
6.8 KB
Accession
0001628280-21-001177
Insider Transaction Report
Form 4
Hall Ashley
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2021-01-28+31,000→ 31,000 totalExercise: $32.12Exp: 2031-01-28→ Common Stock (31,000 underlying) - Award
Common Stock
2021-01-28+7,000→ 22,500 total
Footnotes (1)
- [F1]The options vest over a four (4) year period in equal quarterly installments, the first of which will be May 15, 2021.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001801842
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 5:01 PM ET
- Size
- 6.8 KB